In various pathologies, changes in cerebral metabolite concentrations are accompanied by variations in the broader underlying lipid/macromolecular components. This introduces important biases in quantification at short echo times which, if unaddressed, undermine experiments which compare subjects with different injury severities.
Here we demonstrate the benefits of employing a simple two-point saturation recovery MRS experiment to reduce this bias introduced by pathology – in this case, taking the example of neonatal encephalopathy. This ability to accurately quantify spectra at all pathology severities is crucial for clinical trials, where biases would otherwise suppress sensitivity to important treatment effects.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords